相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up
C. W. Lees et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
S. Schneeweiss et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Infliximab treatment for symptomatic Crohn's disease strictures
A. -L. Pelletier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
Josh Marehbian et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Pneumocystis jiroveci Pneumonia in Patients With Rheumatoid Arthritis Treated With Infliximab: A Retrospective Review and Case-Control Study of 21 Patients
Yukiko Komano et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
H. Fidder et al.
GUT (2009)
Dermatological complications and safety of anti-TNF treatments
Joseph F. Kerbleski et al.
GUT (2009)
Pneumocystis jiroveci (carinii) Pneumonia Following a Second Infusion of Infliximab in a Patient with Ulcerative Colitis
Silvia Estrada et al.
INFLAMMATORY BOWEL DISEASES (2009)
Long-term Outcome of Maintenance Infliximab Therapy in Children with Crohn's Disease
Jeffrey S. Hyoms et al.
INFLAMMATORY BOWEL DISEASES (2009)
Efficacy of Infliximab in Pediatric Crohn's Disease: A Randomized Multicenter Open-label Trial Comparing Scheduled to On Demand Maintenance Therapy
Frank M. Ruemmele et al.
INFLAMMATORY BOWEL DISEASES (2009)
Incidence and Clinical Significance of Immunogenicity to Infliximab in Crohn's Disease: A Critical Systematic Review
Andrea Cassinotti et al.
INFLAMMATORY BOWEL DISEASES (2009)
Absence of Infliximab in Infants and Breast Milk From Nursing Mothers Receiving Therapy for Crohn's Disease Before and After Delivery
Sunanda Kane et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
Justin M. Ko et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2009)
Hepatosplenic T Cell Lymphoma Associated with Infliximab Use in Young Patients Treated for Inflammatory Bowel Disease: Update
Ann Corken Mackey et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)
A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database
John D. Carter et al.
JOURNAL OF RHEUMATOLOGY (2009)
Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception
S. O'Donnell et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata - First 120 cases from the literature including a series of six new patients
Uwe Wollina et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2008)
Erythema multiforme with tumour necrosis factor inhibitors: a class effect?
T. Kain et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay
G. Matulis et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients
V. Gerloni et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Does tumor necrosis factor a inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
Joachim Listing et al.
ARTHRITIS AND RHEUMATISM (2008)
Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action
Angelique N. Collamer et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Autoimmune diseases induced by TNF-targeted therapies
Manuel Ramos-Casals et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2008)
Review and expert opinion on prevention and treatment of infliximab-related infusion reactions
L. L. A. Lecluse et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Infliximab for Inflammatory Bowel Disease in Denmark 1999-2005: Clinical Outcome and Follow-Up Evaluation of Malignancy and Mortality
Sarah Caspersen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Immunogenicity of anti-tumor necrosis factor antibodies - toward improved methods of anti-antibody measurement
Lucien Aarden et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Role of biologics and other therapies in stricturing Crohn's disease: What have we learnt so far?
D. Sorrentino
DIGESTION (2008)
Therapeutic efficacy of infliximab on patients with short duration of Crohn's disease: A Japanese multicenter survey
Takayuki Matsumoto et al.
DISEASES OF THE COLON & RECTUM (2008)
Serious Events with Infliximab in Patients with Inflammatory Bowel Disease A 9-Year Cohort Study in the Netherlands
Hilbert S. de Vries et al.
DRUG SAFETY (2008)
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a Randomized trial
Gert Van Assche et al.
GASTROENTEROLOGY (2008)
Hepatosplenic T cell lymphoma in inflammatory bowel disease
Matthew Shale et al.
GUT (2008)
Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease
Ferenc Izbeki et al.
INFLAMMATORY BOWEL DISEASES (2008)
Tuberculous Chemoprophylaxis Requirements and Safety in Inflammatory Bowel Disease Patients Prior to Anti-TNF Therapy
Yamile Zabana et al.
INFLAMMATORY BOWEL DISEASES (2008)
Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002
Russell Cohen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Infliximab-induced hepatitis: absence of cross-toxicity with etanercept
Gerard Thiefin et al.
JOINT BONE SPINE (2008)
A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis
Daan W. Hommes et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab
Keisuke Ojiro et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Urticarial vasculitis due do infliximab
J. Goulao et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Temporal Relationship Between Antitumor Necrosis Factor-α Antibody Therapy and Recrudescence of Head and Neck Squamous Cell Carcinoma
Samuel H. Engel et al.
LARYNGOSCOPE (2008)
The Effects of HIV on the Sensitivity of a Whole Blood IFN-γ Release Assay in Zambian Adults with Active Tuberculosis
Edward Raby et al.
PLOS ONE (2008)
Drug-induced lupus due to anti-tumor necrosis factor α agents
Michelle F. Costa et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2008)
Is infliximab safe to use while breastfeeding?
Joel Z. Stengel et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Effect of infliximab on small bowel stenoses in patients with Crohn's disease
Nadia Pallotta et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Guidelines for heart transplantation
N. de Jonge et al.
NETHERLANDS HEART JOURNAL (2008)
The effect of anti-tumour necrosis factor α treatment on the antibody response to influenza vaccination
L. B. S. Gelinck et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
T. Takeuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Occurrence of hepatoxicicty and elevated liver enzymes in a Crohn's disease patient treated with infliximab
B. Moum et al.
INFLAMMATORY BOWEL DISEASES (2007)
Lamivudine resistance and exacerbation of hepatitis B in infliximab-treated Crohn's disease patient
Maria Esteve et al.
INFLAMMATORY BOWEL DISEASES (2007)
Heart failure among younger rheumatoid arthritis and Crohns patients exposed to TNF-α antagonists
J. R. Curtis et al.
RHEUMATOLOGY (2007)
Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease
S. A. Clark et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up
Renato Caviglia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Tumor necrosis factor α as a new target for renal cell carcinoma:: Two sequential phase II trials of infliximab at standard and high dose
Michelle L. Harrison et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Interferon γ assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration
Hiroki Takahashi et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
Severine Vermeire et al.
GUT (2007)
Biologic treatment of rheumatoid arthritis and the risk of malignancy - Analyses from a large US observational study
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2007)
Risk for active tuberculosis in inflammatory bowel disease patients
Faten N. Aberra et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Optic neuritis occurring with anti-tumour necrosis factor α therapy
Ismail Simsek et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Antitumor necrosis factor-induced neutropenia:: a case report with double positive rechallenges
E. Montane et al.
CLINICAL RHEUMATOLOGY (2007)
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up
A. Kohn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease
Antonio Salar et al.
GUT (2007)
Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: A cautionary tale?
Joel R. Rosh et al.
INFLAMMATORY BOWEL DISEASES (2007)
Effects of an anti-TNF-α monoclonal antibody, administered throughout pregnancy and lactation, on the development of the macaque immune system
Pauline L. Martin et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2007)
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis
C. W. Lees et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Another paradox in Crohn's disease:: New onset of psoriasis in a patient receiving tumor necrosis factor-α antagonist
Erika Angelucci et al.
INFLAMMATORY BOWEL DISEASES (2007)
Severe cutaneous adverse reactions to drugs
Faith L. Chia et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Psoriasiform and pustular eruption induced by infliximab
Hidetoshi Takahashi et al.
JOURNAL OF DERMATOLOGY (2007)
Infliximab and the risk of latent viruses reactivation in active Crohn's disease
Alessandro Lavagna et al.
INFLAMMATORY BOWEL DISEASES (2007)
Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection
Juan J. Gomez-Reino et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Evidence for boosting Mycobacterium tuberculosis-specific IFN-γ responses at 6 weeks following tuberculin skin testing
A. Naseer et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy:: A review of 84 cases
Nirmal Kaur et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
A case report of tumor necrosis factor-alpha antibody-induced thrombocytopenia associated with emerging IgM anticardiolipin antibody in patients with scleroderma overlap/rheumatoid arthritis
Masahide Hamaguchi et al.
CLINICAL RHEUMATOLOGY (2007)
Serious adverse events with infliximab: Analysis of spontaneously reported adverse events
Richard A. Hansen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation
Frederick Wolfe et al.
ARTHRITIS AND RHEUMATISM (2007)
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease
Stephen I. Rennard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006
S. L. Jakobovits et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab
Angel M. Garcia Aparicio et al.
CLINICAL RHEUMATOLOGY (2007)
Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients
M. C. Kapetanovic et al.
RHEUMATOLOGY (2007)
5-aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
Jonathan P. Terdiman et al.
INFLAMMATORY BOWEL DISEASES (2007)
Ulcerative colitis:: no rise in mortality in a European-wide population based cohort 10 years after diagnosis
O. Hoie et al.
GUT (2007)
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-α therapy
C. H. Roux et al.
RHEUMATOLOGY (2007)
Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research
Dick Menzies et al.
ANNALS OF INTERNAL MEDICINE (2007)
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-α antagonists
H-H. Lee et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children
Jeffrey Hyams et al.
GASTROENTEROLOGY (2007)
Abnormal hepatic biochemistries in patients with inflammatory bowel disease
Flavia D. Mendes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran's Affairs patients receiving tumor necrosis factor alpha antagonists
Jennifer Cole et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease
Ann Corken Mackey et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease
Yukari Masunaga et al.
ANNALS OF PHARMACOTHERAPY (2007)
Serious liver disease induced by infliximab
Gabriel J. Tobon et al.
CLINICAL RHEUMATOLOGY (2007)
Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation
Nicolaas A. Bakker et al.
TRANSPLANT INTERNATIONAL (2007)
Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: Results from a systematic review and meta-analysis
Spencer D. Dorn et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease
Dario Sorrentino et al.
DIGESTION (2007)
Severe varicella infection during treatment with infliximab for Crohn's disease
David Tougeron et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2006)
Bacterial and opportunistic infections during anti-TNF therapy
Anja Strangfeld et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2006)
Vasculitides induced by TNFα antagonists:: a study in 39 patients in France
Bernadette Saint Marcoux et al.
JOINT BONE SPINE (2006)
Drug therapy of inflammatory bowel disease in fertile women
Joyann Kroser et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-α antagonist
F. Tubach et al.
CLINICAL INFECTIOUS DISEASES (2006)
Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor
Kevin L. Winthrop
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis
A. Waljee et al.
GUT (2006)
New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients
Makoto Tanno et al.
CLINICAL RHEUMATOLOGY (2006)
Case report: Evidence for transplacental transfer of maternally administered infliximab to the newborn
Eric A. Vasiliauskas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Safety of anti-TNF-α therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis
C. H. Roux et al.
RHEUMATOLOGY (2006)
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease
Elana A. Maser et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Henoch-Schonlein purpura after etanercept therapy for psoriasis
Annabelle Lee et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2006)
Antirheumatic drugs and the risk of tuberculosis
Paul Brassard et al.
CLINICAL INFECTIOUS DISEASES (2006)
Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions
C. Duburque et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004
T. Jess et al.
GUT (2006)
Infliximab as first-line therapy in severe pediatric Crohn disease
Lissy de Ridder et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
Risks and benefits of infliximab for the treatment of Crohn's disease
Corey A. Siegel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Case report: Lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease
Lauren K. Schwartz et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy - Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2006)
Problems encountered during anti-tumour necrosis factor therapy
Sheetal B. Desai et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2006)
Listeria meningitis in a patient with Crohn's disease - a seldom, but clinically relevant adverse event of therapy with infliximab
F. Dederichs et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2006)
Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies
L. H. Calabrese et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study
C. H. Smith et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
M. H. Schiff et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Fatal aseptic meningoencephalitis following infliximab treatment for inflammatory bowel disease
R Quispel et al.
GUT (2006)
Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: Case report and review of the literature
Maria Bai et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Factors associated with the development of intestinal strictures or obstructions in patients with .Crohn's disease
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy
Elena Dubcenco et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study
BE Sands et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Crohn's disease:: increased mortality 10 years after diagnosis in a Europe-wide population based cohort
FL Wolters et al.
GUT (2006)
The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities - A large, randomized, placebo-controlled trial
R Westhovens et al.
ARTHRITIS AND RHEUMATISM (2006)
Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease
D Sorrentino et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2006)
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients:: A randomized placebo-controlled trial
M Lémann et al.
GASTROENTEROLOGY (2006)
Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus
Fanny Baran-Marszak et al.
CYTOKINE (2006)
Cutaneous lymphocytic vasculitis during TNFα antagonist therapy for polyarthritis
D Wendling et al.
JOINT BONE SPINE (2006)
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab - Results from the ASPIRE trial
JS Smolen et al.
ARTHRITIS AND RHEUMATISM (2006)
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor α antagonists
S Kary et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Review article: infliximab therapy for inflammatory bowel disease - seven years on
P Rutgeerts et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Subfulminant hepatitis B after infliximab in Crohn's disease: Need for HBV-screening?
Gunda Millonig et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia - Associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2006)
Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study
L Biancone et al.
GUT (2006)
Efficacy of infliximab in Crohn's disease.: Results of a retrospective multicenter study with a 15-month follow-up
C Poupardin et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2006)
Oral tuberculosis associated with a treatment with anti-rheumatic drugs
A Kolokotronis et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2006)
Live virus immunization after orthotopic liver transplantation
S Khan et al.
PEDIATRIC TRANSPLANTATION (2006)
Vaccination against influenza in rheumatoid arthritis:: the effect of disease modifying drugs, including TNFα blockers
I Fomin et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006
Mandeep R. Mehra et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2006)
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis
MC Kapetanovic et al.
RHEUMATOLOGY (2006)
Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: Guidelines for clinical approach
Debbie M. Nathan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis
Enzo Ierardi et al.
CLINICAL DRUG INVESTIGATION (2006)
Infliximab dependency in a national cohort of children with Crohn's disease
V Wewer et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
Pulmonary infectious complications associated with anti-TNF alpha therapy (infliximab) for rheumatoid arthritis
Kazuyoshi Imaizumi et al.
INTERNAL MEDICINE (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A woman with rheumatoid arthritis whose condition did not improve during pregnancy
M Ostensen et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2005)
Successful infliximab therapy for a duodenal stricture caused by Crohn's disease
AB Knapp et al.
INFLAMMATORY BOWEL DISEASES (2005)
Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression
S Caillard et al.
TRANSPLANTATION (2005)
Update on tuberculosis and other opportunistic infections associated with drugs blocking tumour necrosis factor α
KL Winthrop
ANNALS OF THE RHEUMATIC DISEASES (2005)
Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy - A prospective case series
T Vassiliadis et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Infliximab treatment does not induce organ-specific or nonorgan-specific autoantibodies other than antinuclear and anti-double-stranded DNA autoantibodies in Crohn's disease
S Nancey et al.
INFLAMMATORY BOWEL DISEASES (2005)
Infections in patients with rheumatoid arthritis treated with biologic agents
J Listing et al.
ARTHRITIS AND RHEUMATISM (2005)
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
K Reich et al.
LANCET (2005)
BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment
LP Ormerod et al.
THORAX (2005)
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents
JH Kwon et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study
CN Bernstein et al.
GASTROENTEROLOGY (2005)
Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas
DA Schwartz et al.
INFLAMMATORY BOWEL DISEASES (2005)
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
A Kandiel et al.
GUT (2005)
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
C Antoni et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
J Askling et al.
ARTHRITIS AND RHEUMATISM (2005)
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis:: A randomized, placebo-controlled study
G Järnerot et al.
GASTROENTEROLOGY (2005)
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists
L Carmona et al.
ARTHRITIS AND RHEUMATISM (2005)
Premedication and infusion reactions with infliximab: Results from a pediatric inflammatory bowel disease consortium
DA Jacobstein et al.
INFLAMMATORY BOWEL DISEASES (2005)
Demyelination-like syndrome in Crohn's disease after infliximab therapy
HJ Freeman et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Survival and safety of treatment with infliximab in the elderly population
H Chevillotte-Maillard et al.
RHEUMATOLOGY (2005)
Macrophage activation syndrome after treatment with infliximab for fistulated Crohn's disease
É Chauveau et al.
PRESSE MEDICALE (2005)
Immunology of cutaneous vasculitis associated with both etanercept and infliximab
MD Srivastava et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al
ETH Molenaar et al.
ARTHRITIS AND RHEUMATISM (2005)
Early measles vaccination in bone marrow transplant recipients
CM Machado et al.
BONE MARROW TRANSPLANTATION (2005)
Infliximab and semen quality in men with inflammatory bowel disease
U Mahadevan et al.
INFLAMMATORY BOWEL DISEASES (2005)
Association of anti-tumor necrosis factor therapy with the development of multiple sclerosis
PJ Enayati et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease
U Mahadevan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Can we alter the natural history of Crohn disease in children?
JS Hyams et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2005)
Infliximab efficacy in pediatric ulcerative colitis
AP Eidelwein et al.
INFLAMMATORY BOWEL DISEASES (2005)
Efficacy and safety of infliximab in patients with ankylosing spondylitis - Results of a randomized, placebo-controlled trial (ASSERT)
D van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2005)
Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease
M Thayu et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2005)
Infections associated with tumor necrosis factor-alpha antagonists
NF Crum et al.
MEDICINE (2005)
Unusual presentation of tuberculosis after infliximab therapy
F Magro et al.
INFLAMMATORY BOWEL DISEASES (2005)
Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study
M Flendrie et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Infections associated with tumor necrosis factor-alpha antagonists
DJ Rychly et al.
PHARMACOTHERAPY (2005)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
High Incidence of Anergy in Inflammatory Bowel Disease Patients Limits the Usefulness of PPD Screening Before Infliximab Therapy
William S. Mow et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Epstein-Barr virus viral load in Crohn's disease - Effect of immunosuppressive therapy
D Reijasse et al.
INFLAMMATORY BOWEL DISEASES (2004)
Infliximab in pediatric ulcerative colitis: Two-year follow-up
P Mamula et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Lamivudine facilitates optimal chemotherapy in hepatitis B virus-infected children with hematological malignancies: A preliminary report
MH El-Sayed et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2004)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2004)
Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients
M Feletar et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis
O Elkayam et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)
Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-α therapy with infliximab for Crohn's disease
FS Velayos et al.
INFLAMMATORY BOWEL DISEASES (2004)
Crohn's disease, infliximab and idiopathic thrombocytopenic purpura
LA Selby et al.
INFLAMMATORY BOWEL DISEASES (2004)
Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001
G Masala et al.
GUT (2004)
Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease
N Kaur et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Fatal staphylococcal sepsis in Crohn's disease after infliximab
KR Herrlinger et al.
INFLAMMATORY BOWEL DISEASES (2004)
Safety of infliximab treatment in pediatric patients with inflammatory bowel disease
CA Friesen et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients:: need for primary prophylaxis
M Esteve et al.
GUT (2004)
Austrian infliximab experience in Crohn's disease: a nationwide cooperative study with long-term follow-up
HH Wenzl et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor
AK Mohan et al.
CLINICAL INFECTIOUS DISEASES (2004)
Colonic sarcoidosis, infliximab, and tuberculosis: A cautionary tale
D Sorrentino et al.
INFLAMMATORY BOWEL DISEASES (2004)
Pneumocystis jiroveci (Carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease
M Seddik et al.
INFLAMMATORY BOWEL DISEASES (2004)
Disseminated primary varicella after initiation of infliximab for Crohn's disease
VS Leung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis
JA Katz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Female infertility after real pouch-anal anastomosis for ulcerative colitis
P Johnson et al.
DISEASES OF THE COLON & RECTUM (2004)
Psoriasiform eruption induced by infliximab
MM Verea et al.
ANNALS OF PHARMACOTHERAPY (2004)
Infliximab therapy in 30 patients with refractory pediatric Crohn disease with and without fistulas in the Netherlands
L de Ridder et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection
LH Calabrese et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Tumor necrosis factor-alpha (TNF-α) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-α antagonist
JS Suominen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Miliary tuberculosis after infliximab therapy in Lebanon
I Uthman et al.
CLINICAL RHEUMATOLOGY (2004)
Infliximab for acute, not steroid-refractory ulcerative colitis:: a randomized pilot study
T Ochsenkühn et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists
L Bergstrom et al.
ARTHRITIS AND RHEUMATISM (2004)
Infliximab in inflammatory bowel disease:: clinical outcome in a population based cohort from Stockholm County
T Ljung et al.
GUT (2004)
The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients
JF Colombel et al.
GASTROENTEROLOGY (2004)
Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone
SM Singh et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection
FA Parke et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Infliximab in the treatment of Crohn's disease - a practical approach - Consensus statement of the Working Group on Chronic Inflammatory Crohn's diseases of the OGGH
H Tilg et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2004)
Safety aspects of infliximab in inflammatory bowel disease patients - A retrospective cohort study in 100 patients of a German University Hospital
J Seiderer et al.
DIGESTION (2004)
Granulomatous infectious diseases associated with tumor necrosis factor antagonists
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
The immunological and clinical spectrum of delayed drug-induced exanthems
Marianne Lerch et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Medical therapy for Crohn's disease strictures
G Van Assche et al.
INFLAMMATORY BOWEL DISEASES (2004)
Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease
CW Thomas et al.
INFLAMMATORY BOWEL DISEASES (2004)
Infliximab-associated retrobulbar optic neuritis
JL Mejico
ARCHIVES OF OPHTHALMOLOGY (2004)
Rheumatoid arthritis and malignant lymphomas
E Baecklund et al.
CURRENT OPINION IN RHEUMATOLOGY (2004)
Mortality in inflammatory bowel disease: A population-based cohort study
T Card et al.
GASTROENTEROLOGY (2003)
Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas
NACS Wong et al.
JOURNAL OF PATHOLOGY (2003)
Pancytopenia in a patient with scleroderma treated with infliximab
Y Menon et al.
RHEUMATOLOGY (2003)
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report
JJ Gómez-Reino et al.
ARTHRITIS AND RHEUMATISM (2003)
Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study
JM Gornet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis:: a randomised controlled trial
CSJ Probert et al.
GUT (2003)
Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate
P Ostuni et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Vaccinations for adult solid-organ transplant recipients: Current recommendations and protocols
A Duchini et al.
CLINICAL MICROBIOLOGY REVIEWS (2003)
Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: A possible healthcare-associated case?
FG De Rosa et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Case reports of heart failure after therapy with a tumor necrosis factor antagonist
HJ Kwon et al.
ANNALS OF INTERNAL MEDICINE (2003)
Histoplasmosis after treatment with anti-tumor necrosis factor-α therapy
KL Wood et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (Remicade) in severe pediatric Crohn disease
JP Cezard et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2003)
Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody)
MJ Burt et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Improvement of liver function tests in patients with primary sclerosing cholangitis and Crohn's disease treated with infliximab
M Regueiro et al.
GASTROENTEROLOGY (2003)
Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type
P Quartier et al.
ARTHRITIS AND RHEUMATISM (2003)
Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
RJ Farrell et al.
GASTROENTEROLOGY (2003)
Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement
M Regueiro et al.
INFLAMMATORY BOWEL DISEASES (2003)
Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management
MA Gardam et al.
LANCET INFECTIOUS DISEASES (2003)
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
F Baert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α-neutralizing agents
NR Slifman et al.
ARTHRITIS AND RHEUMATISM (2003)
Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging
SJ Bell et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model
WV Crandall et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab
A Marchesoni et al.
RHEUMATOLOGY (2003)
Disseminated tuberculosis, pulmonary aspergillosis and cutaneous herpes simplex infection in a patient with infliximab and methotrexate
JM van der Klooster et al.
INTENSIVE CARE MEDICINE (2003)
Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection
JR Peterson et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Survival and cause-specific mortality in ulcerative colitis: Follow-up of a population-based cohort in Copenhagen county
KV Winther et al.
GASTROENTEROLOGY (2003)
Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease
M Holtmann et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2003)
Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor
J Kuruvilla et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2003)
Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy
SA Devos et al.
DERMATOLOGY (2003)
Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept
JH Lee et al.
ARTHRITIS AND RHEUMATISM (2002)
Strictures and response to infliximab in Crohn's disease
AM Weinberg et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Infliximab treatment does not result in an increased risk of intestinal strictures or obstruction in Crohn's disease patients: Accent I study results
GR Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
Infliximab for treatment of steroid-refractory ulcerative colitis
GC Actis et al.
DIGESTIVE AND LIVER DISEASE (2002)
Efficacy and safety of immunization for pre- and post- liver transplant children
H Kano et al.
TRANSPLANTATION (2002)
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers
O Shibolet et al.
BLOOD (2002)
Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study
PDW Kiely et al.
RHEUMATOLOGY (2002)
Mortality and causes of death in Crohn's disease: Follow-up of a population-based cohort in Copenhagen County, Denmark
T Jess et al.
GASTROENTEROLOGY (2002)
Infliximab in treatment of Crohn's disease: the Milan experience
S Ardizzone et al.
DIGESTIVE AND LIVER DISEASE (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study
DP Steensma et al.
BLOOD (2002)
Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection
L Biancone et al.
GASTROENTEROLOGY (2002)
Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis
ATY Chan et al.
POSTGRADUATE MEDICAL JOURNAL (2002)
Infliximab as a novel therapy for pediatric ulcerative colitis
P Mamula et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2002)
Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor
TE Wagner et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Reactivation of histoplasmosis after treatment with infliximab
M Nakelchik et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Ulcerative colitis: Female fecundity before diagnosis, during disease, and after surgery compared with a population sample
KO Olsen et al.
GASTROENTEROLOGY (2002)
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine
GA Dayharsh et al.
GASTROENTEROLOGY (2002)
Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment
L Mayordomo et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2002)
Infliximab treatment for Crohn's disease: One-year experience in a Dutch academic hospital
DW Hommes et al.
INFLAMMATORY BOWEL DISEASES (2002)
Hepatitis B and C virus infection in Crohn's disease
L Biancone et al.
INFLAMMATORY BOWEL DISEASES (2001)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Clinical use of Infliximab in Crohn's disease: the Edinburgh experience
IDR Arnott et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
TNFα down-regulates the Fas ligand and inhibits germ cell apoptosis in the human testis
V Pentikäinen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Mortality associated with infliximab
KB Lankarani
JOURNAL OF CLINICAL GASTROENTEROLOGY (2001)
Infliximab for refractory ulcerative colitis
WY Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2001)
Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment
GP Aithal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: A pilot study
BE Sands et al.
INFLAMMATORY BOWEL DISEASES (2001)
Tumor necrosis factor-α blockade in the treatment of rheumatoid arthritis
EC Keystone
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2001)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
Infliximab for Crohn's disease in clinical practice at the mayo clinic: The first 100 patients
E Ricart et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2001)
Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease
RP Perrillo
GASTROENTEROLOGY (2001)
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
B Bozkurt et al.
CIRCULATION (2001)
Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection
S Campbell et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2001)
Infliximab-associated reversible cholestatic liver disease
VV Menghini et al.
MAYO CLINIC PROCEEDINGS (2001)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Concurrence of inflammatory bowel disease and multiple sclerosis
K Kimura et al.
MAYO CLINIC PROCEEDINGS (2000)
Using an analogous monoclonal antibody to evaluate the reproductive and chronic toxicity potential for a humanized anti-TNFα monoclonal antibody
G Treacy
HUMAN & EXPERIMENTAL TOXICOLOGY (2000)
分享论文
